EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 352 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2020. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $196,020 | -58.1% | 57,653 | +27.7% | 0.00% | – |
| Q2 2023 | $467,714 | 0.0% | 45,146 | 0.0% | 0.00% | – |
| Q1 2023 | $467,714 | -17.9% | 45,146 | -6.4% | 0.00% | – |
| Q4 2022 | $569,762 | -99.9% | 48,244 | -5.0% | 0.00% | -100.0% |
| Q3 2022 | $1,065,935,000 | -34.7% | 50,783 | -3.4% | 0.00% | 0.0% |
| Q2 2022 | $1,632,362,000 | -36.6% | 52,589 | -16.1% | 0.00% | 0.0% |
| Q1 2022 | $2,573,230,000 | +17.2% | 62,670 | +24.0% | 0.00% | 0.0% |
| Q4 2021 | $2,196,277,000 | -24.6% | 50,524 | -13.2% | 0.00% | 0.0% |
| Q3 2021 | $2,914,574,000 | -21.6% | 58,210 | -1.4% | 0.00% | -50.0% |
| Q2 2021 | $3,718,804,000 | -39.7% | 59,038 | -11.1% | 0.00% | -33.3% |
| Q1 2021 | $6,169,782,000 | -2.7% | 66,406 | -6.2% | 0.00% | 0.0% |
| Q4 2020 | $6,343,771,000 | -7.5% | 70,801 | +6.6% | 0.00% | -25.0% |
| Q3 2020 | $6,859,770,000 | +28.7% | 66,387 | -1.5% | 0.00% | +33.3% |
| Q2 2020 | $5,330,624,000 | +24.7% | 67,408 | -8.8% | 0.00% | 0.0% |
| Q1 2020 | $4,275,101,000 | +15.1% | 73,887 | +7.4% | 0.00% | +50.0% |
| Q4 2019 | $3,712,785,000 | -16.7% | 68,819 | -19.3% | 0.00% | -33.3% |
| Q3 2019 | $4,456,190,000 | +16.5% | 85,237 | +7.7% | 0.00% | 0.0% |
| Q2 2019 | $3,824,171,000 | +47.4% | 79,159 | +54.2% | 0.00% | +50.0% |
| Q1 2019 | $2,593,999,000 | -12.1% | 51,346 | +3.2% | 0.00% | -33.3% |
| Q4 2018 | $2,950,780,000 | -3.7% | 49,777 | +6.9% | 0.00% | +50.0% |
| Q3 2018 | $3,064,189,000 | +30.2% | 46,547 | -0.1% | 0.00% | 0.0% |
| Q2 2018 | $2,353,187,000 | +3.8% | 46,607 | +8.2% | 0.00% | 0.0% |
| Q1 2018 | $2,267,214,000 | -89.9% | 43,062 | -91.1% | 0.00% | -89.5% |
| Q4 2017 | $22,389,571,000 | -0.0% | 481,807 | -13.0% | 0.02% | -5.0% |
| Q3 2017 | $22,389,887,000 | +5.0% | 553,520 | -11.9% | 0.02% | -4.8% |
| Q2 2017 | $21,314,435,000 | +11.4% | 628,559 | -4.6% | 0.02% | +5.0% |
| Q1 2017 | $19,130,913,000 | +79130.2% | 658,778 | -10.4% | 0.02% | -25.9% |
| Q4 2016 | $24,146,000 | +4.5% | 735,222 | +0.4% | 0.03% | +8.0% |
| Q3 2016 | $23,098,000 | +19.8% | 732,558 | +6.8% | 0.02% | +13.6% |
| Q2 2016 | $19,284,000 | +68.4% | 685,800 | +117.7% | 0.02% | +69.2% |
| Q1 2016 | $11,448,000 | -28.8% | 314,953 | -21.6% | 0.01% | -27.8% |
| Q4 2015 | $16,073,000 | -3.4% | 401,728 | -31.2% | 0.02% | 0.0% |
| Q3 2015 | $16,637,000 | -24.1% | 583,946 | -12.2% | 0.02% | -14.3% |
| Q2 2015 | $21,923,000 | +35.6% | 665,338 | +18.3% | 0.02% | +31.2% |
| Q1 2015 | $16,171,000 | +25.8% | 562,272 | +19.1% | 0.02% | +33.3% |
| Q4 2014 | $12,855,000 | +21.2% | 472,105 | -5.1% | 0.01% | +9.1% |
| Q3 2014 | $10,605,000 | +30.5% | 497,669 | +37.6% | 0.01% | +37.5% |
| Q2 2014 | $8,126,000 | -47.2% | 361,806 | -40.5% | 0.01% | -50.0% |
| Q1 2014 | $15,377,000 | +8.9% | 608,494 | -0.9% | 0.02% | 0.0% |
| Q4 2013 | $14,122,000 | +20.1% | 614,265 | -0.5% | 0.02% | +6.7% |
| Q3 2013 | $11,756,000 | +45.2% | 617,157 | +9.9% | 0.02% | +50.0% |
| Q2 2013 | $8,098,000 | – | 561,583 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |